Fluoroorganic Division, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500007, India.
Medicinal Chemistry and Pharmacology Division, CSIR-Indian Institute of Chemical Technology, Tarnaka, Hyderabad 500007, India.
Eur J Med Chem. 2014 Jun 10;80:184-91. doi: 10.1016/j.ejmech.2014.04.052. Epub 2014 Apr 18.
A series of novel 1,2,3-triazole substituted N-phenyl nitrone derivatives 5a-e were prepared in three steps starting from 1-substituted-1,2,3-triazole-4-carbaldehydes 2 via Schiff's base formation, reduction followed by oxidation. Similarly, 1,2,3-triazole substituted N-alkyl nitrone derivatives 6a-p were prepared in single step starting from compound 2 on reaction with N-alkyl hydroxylamine hydrochlorides. All the final compounds were screened for anti-inflammatory and anticancer activity against various cancer cell lines. Among the compounds tested, the compounds 5a, 5d, 6a, 6b, 6m and 6o exhibited significant inhibition of IL-1β secretion as a measure of anti-inflammatory activity. Compound 5b, 5c, 6h, 6i and 6o exhibited significant activity against all the cell lines (A549, COLO 205, MDA-MB 231 and PC-3) at IC50 values of <15 μM.
一系列新型 1,2,3-三唑取代的 N-苯基硝酮衍生物 5a-e 通过三步反应从 1-取代-1,2,3-三唑-4-甲酰基化合物 2 合成,该三步反应依次为席夫碱形成、还原和氧化。同样,1,2,3-三唑取代的 N-烷基硝酮衍生物 6a-p 通过化合物 2 与 N-烷基羟胺盐酸盐的反应在一步反应中合成。所有最终化合物都进行了抗炎和抗癌活性筛选,以评估其对各种癌细胞系的抑制作用。在所测试的化合物中,化合物 5a、5d、6a、6b、6m 和 6o 表现出显著抑制白细胞介素-1β(IL-1β)分泌的作用,可作为抗炎活性的衡量标准。化合物 5b、5c、6h、6i 和 6o 在 IC50 值<15 μM 的情况下对所有细胞系(A549、COLO 205、MDA-MB 231 和 PC-3)均表现出显著的活性。